Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
NeoGenomics Clinical Trials
Determine NeoGenomics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of NeoGenomics Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | GDCT0387979 | seribantumab | Oncology | Bile Duct Cancer (Cholangiocarcinoma) ; Bladder Cancer; Breast Cancer; Colorectal Cancer; Esophageal Cancer; Gallbladder Cancer; Head And Neck Cancer; Kidney Cancer (Renal Cell Cancer); Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Sarcomas; Solid Tumor; Uterine Cancer | Phase II | Ongoing, recruiting | Elevation Oncology Inc |
| Plasma-adapted First-line Pembro In NSCLC | GDCT0371606 | Alimta; carboplatin; paclitaxel; pembrolizumab | Oncology | Non-Small Cell Lung Cancer | Phase II | Ongoing, not recruiting | Dana-Farber Cancer Institute Inc;Dana-Farber/Harvard Cancer Center |
| GB1275 Monotherapy and in Combination with an Anti-PD1 Antibody in Patients with Specified Advanced Solid Tumors or in Combination with Standard of Care in Patients with Metastatic Pancreatic Adenocarcinoma | GDCT0343546 | GB-1275 | Oncology | Adenocarcinoma Of The Gastroesophageal Junction; Colorectal Cancer; Esophageal Cancer; Esophageal Squamous Cell Carcinoma (ESCC); Gastric Cancer; Head And Neck Cancer Squamous Cell Carcinoma; Hepatocellular Carcinoma; Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Metastatic Adenocarcinoma of The Pancreas; Metastatic Colorectal Cancer; Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer; Metastatic Pancreatic Cancer; Non-Small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Renal Cell Carcinoma; Small-Cell Lung Cancer; Solid Tumor; Transitional Cell Carcinoma (Urothelial Cell Carcinoma); Triple-Negative Breast Cancer (TNBC) | Phase I/II | Terminated | Gossamer Bio Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer